Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Global Blood Therapeutics, Inc. | d885656ds1a.htm |
| EX-5.1 - EX-5.1 - Global Blood Therapeutics, Inc. | d885656dex51.htm |
| EX-3.4 - EX-3.4 - Global Blood Therapeutics, Inc. | d885656dex34.htm |
| EX-1.1 - EX-1.1 - Global Blood Therapeutics, Inc. | d885656dex11.htm |
| EX-3.7 - EX-3.7 - Global Blood Therapeutics, Inc. | d885656dex37.htm |
| EX-3.5 - EX-3.5 - Global Blood Therapeutics, Inc. | d885656dex35.htm |
| EX-4.1 - EX-4.1 - Global Blood Therapeutics, Inc. | d885656dex41.htm |
| EX-3.2 - EX-3.2 - Global Blood Therapeutics, Inc. | d885656dex32.htm |
| EX-3.6 - EX-3.6 - Global Blood Therapeutics, Inc. | d885656dex36.htm |
| EX-10.2 - EX-10.2 - Global Blood Therapeutics, Inc. | d885656dex102.htm |
| EX-10.8 - EX-10.8 - Global Blood Therapeutics, Inc. | d885656dex108.htm |
| EX-10.12 - EX-10.12 - Global Blood Therapeutics, Inc. | d885656dex1012.htm |
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Global Blood Therapeutics, Inc.:
We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Francisco, California
July 30, 2015